- Home
- NLY vs EXAS Comparison
NLY vs EXAS Comparison
Compare NLY & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLY
- EXAS
- Stock Information
- Founded
- NLY 1996
- EXAS 1995
- Country
- NLY United States
- EXAS United States
- Employees
- NLY N/A
- EXAS N/A
- Industry
- NLY Real Estate Investment Trusts
- EXAS Medical Specialities
- Sector
- NLY Real Estate
- EXAS Health Care
- Exchange
- NLY Nasdaq
- EXAS Nasdaq
- Market Cap
- NLY 10.6B
- EXAS 11.6B
- IPO Year
- NLY 1997
- EXAS N/A
- Fundamental
- Price
- NLY $19.61
- EXAS $59.64
- Analyst Decision
- NLY Strong Buy
- EXAS Strong Buy
- Analyst Count
- NLY 10
- EXAS 16
- Target Price
- NLY $21.56
- EXAS $72.80
- AVG Volume (30 Days)
- NLY 5.4M
- EXAS 2.2M
- Earning Date
- NLY 02-05-2025
- EXAS 11-05-2024
- Dividend Yield
- NLY 13.30%
- EXAS N/A
- EPS Growth
- NLY N/A
- EXAS N/A
- EPS
- NLY N/A
- EXAS N/A
- Revenue
- NLY $369,368,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- NLY N/A
- EXAS $11.81
- Revenue Next Year
- NLY $9.32
- EXAS $11.41
- P/E Ratio
- NLY N/A
- EXAS N/A
- Revenue Growth
- NLY N/A
- EXAS 11.91
- 52 Week Low
- NLY $17.67
- EXAS $40.62
- 52 Week High
- NLY $21.11
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- NLY 47.32
- EXAS 48.86
- Support Level
- NLY $19.65
- EXAS $61.28
- Resistance Level
- NLY $20.00
- EXAS $62.15
- Average True Range (ATR)
- NLY 0.25
- EXAS 2.02
- MACD
- NLY -0.03
- EXAS 0.15
- Stochastic Oscillator
- NLY 25.78
- EXAS 3.39
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The Company owns a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations, credit risk transfer securities, other securities representing interests in or obligations backed by pools of mortgage loans, residential mortgage loans and mortgage servicing rights. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The Company's three investment groups are comprised of the following: Annaly Agency Group, Annaly Residential Credit Group, Annaly Mortgage Servicing Rights Group.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.